India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...
Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no ...
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years.PPF is a rare lung condition, more life-threatening than many ...
St. Luke’s Medical Center Global City has established its Inhaler Clinic Service to optimize the care of patients managing pulmonary disorders such as asthma and Chronic Obstructive Pulmonary Disease ...
TipRanks on MSN
GRI Bio announces positive Phase 2a trial results
GRI Bio ( ($GRI) ) has issued an update. On December 10, 2025, GRI Bio announced positive topline results from its Phase 2a clinical trial of ...
MedPage Today on MSN
Watch Out for Bleeding in These Cancer Patients on Extended Anticoagulation
"Patients with cancer-associated thrombosis are both at risk of recurrent venous thromboembolism and bleeding during extended ...
GRI Bio (GRI) announced topline data from the Phase 2a GRI-0621-IPF-02 clinical trial evaluating GRI-0621 for the treatment of Idiopathic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback